Plain-English translation of NCT06943807 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether analyzing DNA in stool samples can help identify people at risk for stomach cancer before symptoms appear. You would provide a stool sample and answer a questionnaire about your health history. If your results suggest risk, you'd be referred for a camera test (endoscopy) to look inside your stomach and take a small tissue sample if needed.
Stomach cancer is often found late, when it's harder to treat. This trial is exploring whether a simple, non-invasive stool test could catch the disease earlier in people at risk, potentially improving outcomes.
You likely qualify if…
You likely don't qualify if…
You'll provide a stool sample and complete a health questionnaire during an interview with a trained researcher. If your results suggest cancer risk, you'll be referred for an endoscopy (a camera test of your stomach) with a small tissue sample. Those not diagnosed with cancer will be asked to repeat screening annually. Your stool sample may also be stored for future research to improve cancer detection.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China
Enrollment target
~15,000 participants
Started
July 2025
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dazhi Xu, PhD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.